The website of the Clinical Services Journal

CORONAVIRUS NEWS

Common steroids after ‘long COVID’ recovery may cut risk of death by up to 51%

Researchers from the University of Florida Gainesville showed last December that hospitalised patients who seemingly recovered from severe COVID-19 run more than double the risk of dying within the next year, compared to people who experienced only mild or moderate symptoms and who had not been hospitalised, or who never caught the illness.

NHS rolls out life-saving arthritis drug to treat COVID

The NHS is rolling out a cutting-edge, life-saving COVID treatment, which is proven to save lives when given to the most seriously ill COVID patients in hospital.

Unvaccinated with heart problems at risk of serious COVID-19 outcomes

Researchers from Queen Mary University of London have combined evidence from 110 previous COVID-19 studies and found that unvaccinated individuals who contract the virus when they already have high blood pressure, diabetes or major heart damage are up to nine times more likely to suffer serious outcomes, including death, lung failure, admission to intensive care and kidney problems.

Singing techniques can improve quality of life and breathlessness after COVID-19

An online breathing and wellbeing programme helps improve quality of life and breathlessness for people recovering from COVID-19, according to a new study.

Immune system culprit in severe COVID cases found

Yale researchers have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.

High blood pressure and its treatment not risk factors for worse COVID outcomes

High blood pressure and treatments to control it do not increase the risk of hospitalisation and death from Covid-19, according to a large European-wide study which in the UK was co-ordinated at UCLH and UCL.

Access to antivirals expands as part of national study

Thousands more vulnerable people in England are now eligible to receive the UK’s second oral antiviral treatment for COVID-19.

Study details critical role of viral gene ORF8 in COVID-19 outcomes

A research team led by Jae Jung, PhD, Director of Cleveland Clinic’s Global Center for Pathogen & Human Health Research, has uncovered the critical role a viral gene, ORF8, plays in infection and disease outcomes of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

Study finds increased risk of serious blood clots up to six months after COVID-19

A study from Sweden published by The BMJ has found an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after COVID-19 infection, pulmonary embolism (a blood clot in the lung) up to six months, and a bleeding event up to two months.

Link between blood group and severe COVID-19

A new study has analysed over 3000 proteins to identify which are causally linked to the development of severe COVID-19. This is the first study to assess such a large number of proteins for their connection to COVID-19.

Regulations making COVID-19 vaccination a condition of deployment to end

Regulations making COVID-19 vaccination a condition of deployment in health and social care will be revoked on Tuesday 15 March, the Health and Social Care Secretary has confirmed.

Promising drug for treating serious COVID-19 complication in children

Scientists at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) have identified a promising drug candidate for the treatment of multi-inflammatory syndrome in children (MIS-C).

NHS leaders sound alarm over Government’s ‘Living with COVID’ proposal

The NHS Confederation's chief executive, Matthew Taylor, and other health leaders, have raised concerns over the Government's 'Living with COVID-19' strategy.

Vitamin D levels linked to COVID disease severity and mortality

A new study has confirmed that vitamin D levels may positively influence the outcome of COVID-19 infection.

Public urged to sign up to world-first COVID-19 antiviral study

Adults over the age of 50 or with an underlying health condition who test positive for COVID-19 are being urged to sign up for a world-first COVID-19 study which is providing life-saving antivirals to thousands of people.

UK at risk of new variants if poorer countries left unvaccinated

Allowing large numbers of people in low and middle-income countries to go unvaccinated is “a reckless approach to public health” that could lead to new variants of Coronavirus, scientists have warned.

Heparin effective and safe treatment for COVID-19

Researchers from the Australian National University, with King’s Heparin, have discovered that heparin can limit lung damage when inhaled by COVID-19 patients.

Multivariant COVID-19 vaccine booster shows promise

The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in September 2021 and supported by the NIHR, has released positive data.

Scientists identify antibodies that can neutralise omicron

An international team of scientists have identified antibodies that neutralise omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.

COVID-19 vaccine protection wanes after three months, study suggests

The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses.

Upcoming Events

BSG LIVE 22

ICC, Birmingham
20th – 23rd June 2022

EBME Expo 2022

Coventry Building Society Arena, Phoenix Way, Rowleys Green, Coventry CV6 6GE
28th - 29th June

Infection 360: What's trending in infection prevention & control

Edgbaston Stadium, Birmingham
27-28 September 2022

IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022

Bournemouth
17-19 October 2022

UKHCA Conference: Listen Up

Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022

MEDICA 2022

Dusseldorf Germany
14th November - 17th November

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

BSG LIVE 22

ICC, Birmingham
20th – 23rd June 2022

EBME Expo 2022

Coventry Building Society Arena, Phoenix Way, Rowleys Green, Coventry CV6 6GE
28th - 29th June

Infection 360: What's trending in infection prevention & control

Edgbaston Stadium, Birmingham
27-28 September 2022

IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022

Bournemouth
17-19 October 2022

UKHCA Conference: Listen Up

Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022

MEDICA 2022

Dusseldorf Germany
14th November - 17th November

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025